NASDAQ: $RNA Overview of Q2 2026 Results Atrium Therapeutics has officially released its financial results for the second quarter of 2026. As the company continues to navigate the complex biopharmaceutical landscape, these latest figures offer stakeholders a detailed look at the organization’s fiscal health and operational progress during the three-month period ending June 30, 2026.…